{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:06Z","timestamp":1788871866123,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS 26511"],"award-info":[{"award-number":["NS 26511"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM 69829"],"award-info":[{"award-number":["GM 69829"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.bcp.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T04:14:46Z","timestamp":1258085686000},"page":"1025-1035","source":"Crossref","is-referenced-by-count":5,"title":["Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivative"],"prefix":"10.1016","volume":"79","author":[{"given":"Hinako","family":"Suga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J.","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.11.005_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(25)26023-2","article-title":"An unusual type of sympathetic ganglionic stimulant","volume":"132","author":"Roszkowski","year":"1961","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.11.005_bib2","first-page":"1014","article-title":"Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition","volume":"40","author":"McKinney","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib3","first-page":"231","article-title":"Measurement of agonist-stimulated [35S]GTP gamma S binding to cell membranes","volume":"106","author":"Lazareno","year":"1999","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bcp.2009.11.005_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.108.145219","article-title":"Selectivity of agonists for the active state of M1\u2013M4 muscarinic receptor subtypes","volume":"328","author":"Figueroa","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.11.005_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1476-5381.1983.tb09388.x","article-title":"The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart","volume":"78","author":"Birdsall","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib6","doi-asserted-by":"crossref","first-page":"29312","DOI":"10.1074\/jbc.M803801200","article-title":"A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric\/allosteric ligand","volume":"283","author":"Valant","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for modeling G-protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure\u2013function analysis of rhodopsin-like receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci"},{"key":"10.1016\/j.bcp.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0026-895X(25)14327-7","article-title":"Modification of the binding properties of muscarinic receptors by gallamine","volume":"23","author":"Stockton","year":"1983","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0026-895X(25)09800-1","article-title":"Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors","volume":"46","author":"Waelbroeck","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/1389557054023251","article-title":"Allosterism at muscarinic receptors: ligands and mechanisms","volume":"5","author":"Birdsall","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2009.11.005_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.107.037630","article-title":"Structure\u2013function studies of allosteric agonism at M2 muscarinic acetylcholine receptors","volume":"72","author":"May","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3565(25)23240-2","article-title":"Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine","volume":"249","author":"Ringdahl","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.11.005_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/jpet.108.141234","article-title":"Use of acetylcholine mustard to study allosteric interactions at the M(2) muscarinic receptor","volume":"327","author":"Suga","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.11.005_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0026-895X(25)13506-2","article-title":"The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex","volume":"28","author":"Ehlert","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/jm00163a046","article-title":"Tertiary 2-haloethylamine derivatives of the muscarinic agent McN-A-343, [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride","volume":"33","author":"Ringdahl","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2009.11.005_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0006-2952(03)00068-6","article-title":"Comparison of pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination","volume":"65","author":"Griffin","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0026-895X(25)09442-8","article-title":"Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats","volume":"38","author":"Ehlert","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/jpet.108.136960","article-title":"Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor","volume":"325","author":"Ehlert","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.11.005_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","article-title":"Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods","volume":"33","author":"Ehlert","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/jm00127a031","article-title":"Dimethylsulfonium analogues of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl)carbamoyl]oxy]-2-butynyl] dimethylsulfonium perchlorates","volume":"32","author":"Mellin","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2009.11.005_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1476-5381.1976.tb07708.x","article-title":"The inhibitory effect of gallamine on muscarinic receptors","volume":"58","author":"Clark","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1124\/mol.62.6.1492","article-title":"Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors","volume":"62","author":"Lazareno","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0026-895X(25)13766-8","article-title":"Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type","volume":"32","author":"Waelbroeck","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.11.005_bib24","doi-asserted-by":"crossref","first-page":"18836","DOI":"10.1074\/jbc.M000112200","article-title":"Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors","volume":"275","author":"Jakubik","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.11.005_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/bst0310029","article-title":"Structure and activation of muscarinic acetylcholine receptors","volume":"31","author":"Hulme","year":"2003","journal-title":"Biochem Soc Trans"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209009691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209009691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:17:12Z","timestamp":1739409432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209009691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0006295209009691"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.11.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}